From early clinical trials to an established CAR-T Cell Therapy Program, Mayo Clinic has delivered the transformative therapy to over 1,500 patients.

A decade ago, chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, was an experimental treatment only available through clinical trials. Today, Mayo Clinic offers CAR-T cell therapy at all three sites in Arizona, Florida and Minnesota and continues to explore new frontiers for the life-changing treatment.

That progress traces back to Mayo Clinic’s early involvement in research exploring CAR-T cell therapy for patients with few remaining options.